<乌鸦传媒>Reassuring Data on Two-Dose Hep B Vaccine, Risk of Acute MI No significantly greater risk with Heplisav-B versus Engerix-B Mar 28, 2022
<乌鸦传媒>Default Order in Hospitals' EHR Doubles Hepatitis C Screening About 70% of patients completed screening with intervention versus 38% with conventional alert Mar 17, 2022
<乌鸦传媒>Getting a Cure to Hepatitis C Patients Who Use Injection Drugs Randomized trial found that HCV care housed at a harm reduction center improved chances Mar 14, 2022
<乌鸦传媒>SubQ Infliximab Works for IBD; FDA Clears Complex Colonoscopy Tool; IBS & Diet News and commentary from the world of gastroenterology and hepatology Feb 18, 2022
<乌鸦传媒>Universal HCV Screening in Pregnancy Boosts Detection More cases found verses risk-based approach, also IDs perinatal transmission, researcher says Feb 16, 2022
<乌鸦传媒>Novel Strategy Slashes HBV Vertical Transmission Sans Immunoglobulin Cambodian study finds antenatal antiviral effective if used for long enough Feb 15, 2022
<乌鸦传媒>Recurrent Autoimmune Hepatitis Post-Liver Transplant: What Are the Risks? Probability of recurrent disease more than doubled from 5 to 20 years later Feb 09, 2022
<乌鸦传媒>Need for Liver Transplants Rising Sharply in Seniors Post-transplant mortality still higher versus younger patients, but improving over time Nov 17, 2021
<乌鸦传媒>FMT Benefits Last a Few Years in Severe Alcoholic Hepatitis Patients More research needed to determine impact on clinical outcomes versus standard of care Nov 14, 2021
<乌鸦传媒>Fewer Hepatitis C Patients Seeking Treatment of Late Accelerated declines in 2020 only the latest in a downward trajectory Nov 12, 2021
<乌鸦传媒>ACIP: All Adults Ages 59 and Younger Should Get Hep B Vaccine Committee also passed new recommendations on vaccines against Ebola, orthopoxviruses Nov 03, 2021
<乌鸦传媒>Advanced Fibrosis Tied to Most Severe Outcomes in NAFLD Study found higher risk of liver decompensation, death in those with bridging fibrosis, cirrhosis Oct 20, 2021
<乌鸦传媒>When It Comes to Hep B Vaccine, Three Antigens May Be Better Than One Vaccine licensed in Israel, but not yet in the U.S. Oct 12, 2021
<乌鸦传媒>High-Dose HBV Revaccination Better Protects HIV Patients Phase III trial saw more and longer-lasting responses with double the dose Aug 24, 2021
<乌鸦传媒>Some Liver Transplant Patients Got Hepatitis B From Donors Injection drug use may be mostly to blame, researcher says Jul 10, 2021
<乌鸦传媒>Resmetirom Delivers Promising Outcomes in NASH Without Invasive Follow-Up Real-world study also identifies noninvasive markers for treatment response Jun 29, 2021
<乌鸦传媒>Adding PD-1 Inhibitor Shows Promise in Potentially Resectable HCC "Safe and successful conversion therapy" with hepatic arterial infusion chemo plus sintilimab Jun 28, 2021
<乌鸦传媒>Tenofovir Treatment Lessened Risk of Severe COVID Infection in HBV But expert questions conclusion of small study from Spain Jun 27, 2021
<乌鸦传媒>Bulevirtide Shows Promise in Tough-to-Treat Hepatitis D Significant responses seen with novel agent for "devil" disease Jun 27, 2021
<乌鸦传媒>Big Jump in Monthly Average Hospital Admission for Alcoholic Hepatitis Post-Pandemic Long-term impact of alcohol uptake on liver health during COVID-19 crisis remains unknown Jun 26, 2021
<乌鸦传媒>The Murky Post-Pandemic Future of Hepatitis C Elimination in the U.S. Modeling study demonstrates need to rebound or risk losing progress Jun 25, 2021
<乌鸦传媒>Is Dynamic AFP-R Key to Transplant Selection in Liver Cancer? Dynamic alpha-fetoprotein response improved prediction of patient outcomes May 05, 2021
<乌鸦传媒>FDA Panel Splits on Anti-PD-1 Monotherapy in HCC All thumbs up for pembrolizumab, pending further data, but no such luck for nivolumab Apr 30, 2021
<乌鸦传媒>Copay Assistance Programs Help Patients but Confuse Them Too Insurers keep track of their use and in some cases won't apply them to patient deductibles Jan 13, 2021
<乌鸦传媒>Trial Finds Semaglutide Resolves NASH in Many Obese Adults But "unexpected" lack of improvement in fibrosis stage vs placebo Nov 13, 2020
<乌鸦传媒>Fatty Liver Afflicts Most 9/11 'Ground Zero' Workers Researchers blame toxin exposure during recovery and cleanup effort Apr 30, 2020
<乌鸦传媒>Hep C on the Rise in Younger Adults Data inform CDC's new screening recommendations Apr 10, 2020
<乌鸦传媒>Respiratory and GI Symptoms? Don't Rule Out COVID-19 Commentary also urges PPE use given potential fecal shedding of virus Mar 17, 2020
<乌鸦传媒>Hep B Cure Research: The Long Road Ahead Combination approaches, novel agents may lead the way Jan 03, 2020
<乌鸦传媒>ACIP: Hep A and MenB Vaccine Recommendations Updated Hepatitis A recommendations expanded for people with HIV; panel stands pat on flu vaccine policy Jun 28, 2019
<乌鸦传媒>Lines Blur Between Non-Alcoholic and Alcoholic Fatty Liver Diagnostic criteria for disease types need updating for better patient stratification Jun 04, 2019
<乌鸦传媒>Core Protein Inhibitor: A Key to Eventual HBV Cure? Entecavir plus novel core protein inhibitor led to dramatic declines in hepatitis B DNA, RNA Apr 14, 2019
<乌鸦传媒>Combo Tx With 'Entry Inhibitor' Latest Hope in Treating Hep D Myrcludex B and interferon shows promise in HBV/HDV co-infection Apr 12, 2019
<乌鸦传媒>Cirrhosis 'Turning Point' in Fatty Liver Progression Most patients identified with decompensated event, real-world study finds Apr 11, 2019
<乌鸦传媒>Cure for Hepatitis B Pushed Disease affecting 257 million people needs better treatment Apr 10, 2019
<乌鸦传媒>What's Behind London's Falling HCV Rates in HIV+ MSM? City cut HCV incidence in this population by almost 70% in 5 years Mar 08, 2019
<乌鸦传媒>Did OxyContin Reformulation Boost HCV Rates? Association suggests "unintended consequence" of abuse deterrent opioids Feb 04, 2019
<乌鸦传媒>HCV Combo Pill a Winner in Untreated Cirrhotic Patients High SVR12 rate suggests 8-week treatment could be used for this population Nov 14, 2018
<乌鸦传媒>Hepatitis C Treatment Works Well for Young Kids Nearly all children treated with sofosbuvir/ledipasvir achieved sustained response Nov 12, 2018
<乌鸦传媒>Pregnant Women at Risk for HCV Benefit from Universal Screen Test deemed more efficient, cost-effective diagnostic approach versus risk-based screening Nov 11, 2018
